Hypertension Due to Antiangiogenic Cancer Therapy With Vascular Endothelial Growth Factor Inhibitors: Understanding and Managing a New Syndrome
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference98 articles.
1. Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer;Welti;J Clin Invest,2013
2. VEGF-directed blood vessel patterning: from cells to organism;Bautch;Cold Spring Harb Perspect Med,2012
3. VEGF/VEGFR pathway inhibitors as anti-angiogenic agents: present and future;Sharma;Curr Cancer Drug Targets,2011
4. The VEGF pathway in cancer and disease: responses, resistance, and the path forward;Kieran;Cold Spring Harb Perspect Med,2012
5. VEGF targets the tumour cell;Goel;Nat Rev Cancer,2013
Cited by 111 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Settling the score: what composite measures of social determinants tell us about hypertension risk;JNCI Cancer Spectrum;2024-09-02
2. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment;Drug Design, Development and Therapy;2024-09
3. Cardiovascular adverse events associated with PARP inhibitors for ovarian cancer: a real world study (RWS) with Bayesian disproportional analysis based on the FDA adverse event reporting system (FAERS);Expert Opinion on Drug Safety;2024-08-12
4. Orthostatic hypotension is associated with higher levels of circulating endostatin;European Heart Journal Open;2024-04-10
5. Onco-Hypertension: A Continuously Developing Field between Cancer and Hypertension;International Journal of Molecular Sciences;2024-03-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3